Failed inferior alveolar nerve block in a cardiac patient: how much anesthetic is safe?

Lidocaine: 2% = 20 mg/mL, so one 1.8 mL cartridge = 36 mg. The maximum is 7 mg/kg up to an absolute cap of 300 mg. For 70 kg: 7 × 70 = 490 mg, which exceeds the cap, so the working limit is 300 mg. 300 ÷ 36 ≈ 8.3 cartridges.

Epinephrine: 1:100,000 = 0.01 mg/mL, so one cartridge contains 1.8 × 0.01 = 0.018 mg. A commonly used conservative ceiling for a patient with significant cardiovascular disease is 0.04 mg of epinephrine; 0.04 ÷ 0.018 ≈ 2.2 cartridges.

Epinephrine is the binding constraint. She has already received 1.8 mL, i.e. 0.018 mg of epinephrine and 36 mg of lidocaine, so she has roughly one more cartridge of this solution before reaching the conservative epinephrine ceiling - far short of the 300 mg lidocaine limit. Quoting 'eight cartridges' to her would be correct arithmetic and the wrong answer.

If more anesthesia is genuinely required, the move is to change the solution rather than push the epinephrine: 3% mepivacaine plain (30 mg/mL, max 6.6 mg/kg, 400 mg cap) or 4% articaine with 1:200,000 epinephrine (0.009 mg per cartridge), with a note to her physician if a vasoconstrictor is still needed.

Differential:

1. Accessory innervation - the mylohyoid nerve can supply the mesial root region of mandibular molars, and crossover fibers from the contralateral side are possible. Lip numbness only proves the main trunk was reached; it does not prove every fiber was blocked.
2. Insufficient volume or inadequate diffusion at an inflamed site, where tissue pH is lower and the nerve is hyperexcitable.
3. Anatomical variation - accessory canals or a bifid canal system, or a variant that the standard block simply does not cover.
4. Anxiety amplification - real, but a diagnosis of exclusion; do not reach for it first.

Next steps, in order:

• Re-test with a light periodontal probe rather than a sharp explorer, so you are measuring response and not provoking it.
• Supplemental buccal infiltration of 4% articaine 1:200,000 (about 0.009 mg epinephrine) or a periodontal ligament injection with plain mepivacaine at the mesial site. Both add little or no epinephrine.
• Avoid a second full lidocaine block purely for volume; with her ceiling you have about one cartridge left and it should buy coverage, not more of the same.
• Reserve Gow-Gates or Vazirani-Akinosi for a subsequent appointment if the supplemental technique fails.

Monitor blood pressure and pulse, but do not rely on heart rate to detect epinephrine effect - metoprolol blunts tachycardia.

She should not stop it, and you should not suggest that she does. Low-dose aspirin (81 mg) produces an irreversible platelet effect, but it does not create bleeding that local measures - pressure, gauze, topical hemostatic agent - cannot control during scaling and root planing. The thrombosis risk of stopping outweighs a manageable bleeding risk, and advising a change in a cardioprotective medication is outside your scope.

What would change the answer: a different drug or a different question. Warfarin is not managed by stopping it either, but an INR drawn within the last day or two and an international normalized ratio above the therapeutic range is a reason to check with the prescriber before extensive instrumentation. A direct oral anticoagulant, dual antiplatelet therapy, or a recent stent or stroke changes the conversation and warrants a prescriber contact - but the decision still belongs to the prescriber, not the hygienist.

The test-taking point: 'patient takes aspirin' is a fact that changes technique and hemostatic preparedness, not one that cancels treatment or requires a drug holiday.